Biovertis AG Information

Biovertis is a privately-held biotechnology company that discovers and develops novel classes of small molecule antibiotics to overcome bacterial resistance. Since its inception in 2003, Biovertis has developed into a fully integrated biopharmaceutical company with an advanced pipeline and distinct R&D expertise in the field of anti-infectives. The Company has established a highly efficient drug discovery process based on structural biology and runs several proprietary anti-bacterial programmes, all of which have novel therapeutic modes of action and a strong potential to combat the increasing threat of bacterial resistance. To date, Biovertis has secured private equity funding of €21 million from institutional investors. The company is based in Vienna, Austria, with a subsidiary in Munich, Germany and currently employs a staff of 35.